Better outcome of COVID-19 positive kidney transplant recipients during the unremitting stage with optimized anticoagulation and immunosuppression.

Torki M AlOtaibiOsama Ashry GheithMohammed M AbuelmagdMohammed AdelAhmed K AlqallafNabil A ElserwyMohamed ShakerAhmad M AbbasAyman M NagibPrasad NairMedhat A HalimTarek MahmoudMahmoud M KhaledMohamed A HammadZoheer A FayyadAhmed F AttaAhmed Y MostafaAhmed S DrazZakaria E ZakariaKhaled A AteaHasaneen H AboatyaMohamed E AmeennMohamed A MonemAmro M Mahmoud

Published in: Clinical transplantation (2021)

Better outcome of COVID-19-positive KTR in our cohort during this unremitting stage could be due to the younger age of patients and early optimized management of anticoagulation, modification of immunosuppression, and prompt treatment of secondary bacterial infections. Mild cases can successfully be managed at home without any change in immunosuppression.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
atrial fibrillation
venous thromboembolism
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
patient reported outcomes
respiratory syndrome coronavirus
combination therapy
replacement therapy